Decreased graft-versus-host disease (GVHD) in cord blood (CB) transplantation may be attributed to the immunological immaturity and susceptibility to apoptosis of CB mononuclear cells (MNCs). Cytokines like interleukin (IL)-12 and IL-15 may be used for in vivo administration or ex vivo expansion of lymphoid cells for more rapid recovery following stem cell transplant, and for providing a graft-versus-leukemia (GVL) effect. We investigated the effects of IL-12 and IL-15, alone or in combination on apoptosis and proliferation of both CB and adult peripheral blood ( used as an alternative to bone marrow for transplants in children with immunological and hematological disorders.
used as an alternative to bone marrow for transplants in children with immunological and hematological disorders.
1,2 A recent study established that recipients of CB transplants from HLA-identical siblings had a lower incidence of acute and chronic GVHD than recipients of BM transplant from HLA-identical siblings. 3 Expansion and activation of cord blood cells by cytokines might greatly benefit patients undergoing stem cell transplantation by increasing resistance against viral infections and providing graft-versus-leukemia (GVL) effects through enhancement of cytotoxic T lymphocyte function and natural killer (NK) activity. 4, 5 Interleukin (IL)-12 is a 75 kDa heterodimeric protein that is secreted by macrophages, monocytes and dendritic cells, and stimulates NK and T cells. 6 Another recently cloned cytokine, IL-15, using the ␤ and ␥ c subunits of the IL-2 receptor (IL-2R) complex and a unique ␣ chain for binding and signal transduction, also played an important role in enhancing various lymphocyte functions, including T and NK cytotoxicity. 7 The IL-15R has a broader tissue distribution than IL-2R, as the expression of IL-15 mRNA has been detected in placenta, skeletal muscle, and activated monocytes. 7, 8 The level of mRNA expression and production of both IL-12 and IL-15 have been shown to be decreased in CB MNCs compared to that in adult MNCs. 9 We have previously demonstrated the ability of IL-12 and IL-15 in enhancing various NK cytolytic functions and CD16/56 expression in cord blood and in HIV-infected subjects. [10] [11] [12] UCB T cells and NK cells have a potential to proliferate as strongly as adult peripheral blood (APB) lymphocytes upon stimulation with cytokines. 13 Several studies examined the immunological nature of UCB lymphocytes and showed that programmed cell death (apoptosis) is a key phenomenon for immunological tolerance or anergy, 14, 15 thereby contributing to the lower incidence of GVHD. Previous studies have shown that UCB cells had low levels of expression of CD95 and CD95 ligand, 16 in comparison with APB MNCs, and were resistant to apoptosis upon primary simulation with anti-CD3 monoclonal antibody. However, they are much more likely to be induced to apoptose by allo-priming than adult lymphocytes. 17 Although the ability of IL-12 and IL-15 to augment proliferation and activation of CB MNCs is well documented, their effect on apoptosis of CB MNCs has not been well characterized.
The aim of this study is to investigate the effect of IL-12 and IL-15, alone or in combination, on apoptosis and proliferation of UCB MNCs and APB MNCs. We sought to determine which CB lymphocyte subsets (CD4 + , CD8 + or CD56 + ) were particularly susceptible to cytokineinduced apoptosis and proliferation. The influence of cytokines on Fas (CD95) expression of CB MNCs was also explored.
Materials and methods

Preparation of mononuclear cells and culture with cytokines
MNCs were obtained from normal adult volunteers and from term newborn umbilical cords following normal vaginal deliveries according to guidelines established by the Human Subjects Protection Committee of our institution. Cord blood was collected in sterile tubes and was processed within 24 h of birth. MNCs were separated from heparinized blood using Ficoll-Hypaque density gradient centrifugation. The isolated cells were resuspended at 1 × 10 6 /ml in RPMI-1640 (Irvine Scientific, Santa Ana, CA, USA) supplemented with 10% heat-inactivated fetal calf serum (FCS). MNCs were then placed in a 25 cm 2 tissue culture flasks with no cytokines or with recombinant cytokines IL-15 (Pepro Tech EC, London, UK) at 10 ng/ml, and IL-12 (Pepro Tech EC) at 1 ng/ml for 4-5 days at 37°C in 5% CO 2 . Because of the short half-life of the cytokines, they were added every other day to the cultures. The IL-15 and IL-12 concentrations had been previously determined to be optimal. [10] [11] [12] We observed that incubating CB MNCs with IL-15 at 1, 10 or 100 ng/ml produced a dose-dependent increase in NK activity that plateaued at 10 ng/ml. 10 IL-12 at 1 ng/ml was comparable to the peak serum levels that could be achieved by in vivo administration of IL-12 in patients with advanced renal cell carcinoma. 18 
Measurement of apoptotic cell death by subdiploid DNA content using flow cytometry
The percentage of apoptotic cells was determined by DNA staining with propidium iodide (PI) followed by flow cytometric analysis as previously described. 19 
Detection of apoptosis by TdT-mediated dUTP nick endlabeling (TUNEL) assay
Labeling of DNA strand breaks with fluorescein and analysis by flow cytometry allows for quantitative analysis of apoptosis. 20 The cells were fixed in 1% paraformaldehyde in PBS at RT for 30 min, washed with PBS, and followed by the incubation of ice-cold 70% ethanol at least for 4 hrs. Cells were then washed twice with PBS and resuspended in TUNEL reaction mixture, including trideoxynucleotide transferase (TdT) and FITC-conjugated dUTP. After an incubation for 60 min at 37°C in a humidified atmosphere in the dark, cells were washed and resuspended in 0.1% Triton X-100 containing 1% of bovine serum albumin (BSA), and then analyzed by flow cytometer.
Proliferation assays
Cytokine-induced proliferation was measured by incubating 2 × 10 5 /well with IL-12 and IL-15 under the condition indicated for 3 days. Phytohemaagglutinin (PHA) at 5 g/ml was also tested for comparison. 
Statistics
Student's t-test was used to compare the reported means with standard deviation (s.d.) or standard error of mean (s.e.m.) for the different variables. The n refers to the number of experiments performed. Groups being compared were considered significantly different if P was less than 0.05.
Results
Survival kinetics of CB and APB MNCs cultured with IL-12 and IL-15
To determine the optimal time-point for apoptosis assays, the viability of CB and APB MNCs was examined daily using trypan blue dye exclusion under different culture conditions (Figure 1 ). Without the presence of cytokines, the percentage of viable CB MNCs fell to 73.4 ± 12.2% (mean ± s.d.) on day 5 (Figure 1a) , significantly less than that of corresponding APB MNCs (92.2 ± 3.7%, P Ͻ 0.01, Figure 1b ). On day 5, the viability of CB MNCs was decreased by IL-12 (63.7 ± 12.1%, P = 0.02), or IL-15 (65.3 ± 9.8%, P = 0.06) alone compared to media, while the viability of APB MNCs was not altered by either cytokine. 
Effect of IL-12 and IL-15 on apoptosis of CB and APB MNCs
CB and APB MNCs were harvested on day 5 for cell cycle analysis using PI staining followed by flow cytometry. PI binds to DNA, allowing the identification of cells at apoptotic (M1), resting (M2) and proliferating (M3) stages by their variable DNA content (Figure 2a and b) . Without cytokines, a greater percentage of CB MNCs underwent apoptosis than corresponding APB MNCs (5.5 ± 0.7% vs 4.2 ± 0.6%, P Ͻ 0.05, Figure 3a) . (1 ng/ml) alone (5.9 ± 0.6%, P = 0.32), but did significantly increase on incubation with IL-12+IL-15 (9.1 ± 0.9%, P Ͻ 0.001). The percentages of apoptotic cells in APB MNCs was not influenced by IL-12 (3.3 ± 0.8%, P = 0.23), but was increased with IL-15 (5.3 ± 0.7%, P = 0.04) and further increased with IL-12+IL-15 (7.9 ± 1.0%).
When quantitated by the TUNEL assay (Figure 3b ), the percentages of apoptotic cells were similar between CB MNCs (8.0 ± 6.4%) and APB MNCs (6.7 ± 2.5%, P = 0.58) when cultured in the absence of cytokines. However, CB samples in the presence of IL-12, IL-15 or IL-12+IL-15 contained a greater percentage of apoptotic cells than did corresponding APB samples. The percentage of apoptotic cells in CB MNCs was significantly increased with IL-12 (11.7 ± 7.3%, P = 0.02), and IL-15 (15.6 ± 5.6%, P = 0.02), while that of APB MNCs was not affected by either cytokine. Similar to results of PI staining, IL-12+IL-15 produced the greatest degree of increment of apoptosis in both CB and APB MNCs, resulting in about two-fold increase of apoptotic cells in CB MNCs compared with media only (17.9 ± 4.6% vs 8.0 ± 6.4%, P = 0.008).
Effect of IL-12 and IL-15 on proliferation of CB and APB MNCs
We next examined the effect of IL-12 and IL-15 on proliferation of CB and APB MNCs (Figure 4) . Using PI stain-Bone Marrow Transplantation ing combined with flow cytometry (Figure 4a ), the percentage of proliferating cells (cells in M3 fraction, Figure 2 ) in CB MNCs was increased by IL-12 (5.6 ± 0.3%, P = 0.004, compared to 4.4 ± 0.5% in media), and was further increased with IL-15 (12.9 ± 0.9%, P Ͻ 0.001) and IL-12+IL-15 (10.5 Ϯ 0.8%, P Ͻ 0.001). The percentages of proliferating cells in APB MNCs responded to cytokines in a similar fashion to those in CB MNCs, except that IL-12 had no effect on proliferation of APB MNCs. The results of lymphocyte proliferation assay are shown in Figure 4b . Higher proliferation capacity, with 649 ± 287 counts per minute (c.p.m.), was detected from PHA-activated CB MNCs for 3 days. This was significantly greater than that for APB MNCs (328 ± 124 c.p.m., P Ͻ 0.05). IL-15 enhances the proliferation of CB MNCs from 328 ± 137 to 437 ± 89 c.p.m. (P = 0.20), greater than that achieved with corresponding APB MNCs. IL-12 had no effect on proliferation of CB MNCs alone, and inhibited the proliferation when combined with IL-15.
Determination of apoptosis and proliferation of CD4
+ , CD8
+ and CD56 + CB lymphocyte subsets by PI staining
We further determined the effect of cytokines on apoptosis and proliferation of particular CB lymphocyte subsets. Cultured CB MNCs were also harvested on day 5 and stained with anti-CD4, anti-CD8 and anti-CD56, respectively, and then subjected to cell cycle analysis using PI staining fol- 
Effect of IL-12 and IL-15 on CD95 expression on CD3
+
or CD56
+ CB subsets CD95 and its ligand mediate a signal for cell death by apoptosis, and have a crucial role in the homeostasis of hematopoietic cell populations. Table 1 + mononuclear cells, as assessed by PI staining with flow cytometry (n = 14). *P Ͻ 0.05/**P Ͻ 0.01, compared to Medium.
Table 1
Effect of IL-12 and IL-15 on CD3/CD95 (double-positive and CD56/CD95 expression of CB MNCs
Medium
IL-12 IL-15 IL-12ϩIL-15 (1 ng/ml) (10 ng/ml)
CD3/95 9.3 ± 3.5 40.9 ± 11.5** 40.6 ± 13.0* 59.5 ± 10.5* CD56/95 1.9 ± 0.7 13.8 ± 2.4** 26.6 ± 7.8* 18.3 ± 7.5* Data (%) expressed as mean ± s.e.m. obtained from six cord samples *P Ͻ 0.05/**P Ͻ 0.01, compared to medium.
CD3
+ cells, while producing much less of an effect on CD95 expression of CD56 + cells than IL-15 alone.
Discussion
CB transplantation represents an encouraging alternative to BM transplantation due to its easier accessibility, less GVHD, and possible allowance for more HLA mismatches. Apoptosis plays a crucial role in the homeostasis of hematopoietic cell population and also the process of GVHD. In this study, we investigated the effect of IL-12 and IL-15 alone, as well as the combination of both cytokines on apoptosis and proliferation of CB MNCs. The results in the study indicated that the combination of IL-12 and IL-15 usually induced a greater degree of CB and APB apoptosis than either cytokine alone and IL-15 is superior to IL-12
Bone Marrow Transplantation in enhancing the proliferative response in CB and APB MNCs. More cells in CD8 + and CD56 + CB subsets responded to the cytokine-inducing apoptosis than CD4 + cells. However, all three subsets proliferated when cytokines were added alone or together in the cultures.
We provided the first in-depth study to examine the effect of IL-12 and IL-15 on apoptosis of CB MNCs. We found that IL-12 or IL-15 alone increased the percentage of apoptotic cells in CB MNCs as assessed by TUNEL assays, an effect not observed using PI assays. Greater susceptibility to spontaneous and cytokine-induced apoptosis was also found in CB MNCs, compared to APB MNCs. TUNEL is considered an sensitive indicator of early apoptotic cells as it detects DNA fragments enriched in the cytoplasm of dying cells, which might explain the higher levels obtained with TUNEL assays. IL-12 has been implicated in a negative feedback loop that enhanced apoptosis. 21 In addition, our previous study demonstrated that while shortterm incubation with IL-12 enhanced NK activity, IL-12 in long-term culture reduced viable MNC recovery and NK function, in comparison with IL-2 and IL-15. [10] [11] [12] The increased apoptosis of CB MNCs in response to IL-15 in our study is contradictory to previous reports showing that IL-15 has anti-apoptotic properties, as it could maintain the survival of memory T cells and NK cells in vivo. 22, 23 Both the results of PI and TUNEL assays showed that IL-12+IL-15 further augmented the CB apoptotic response compared to either cytokine alone, suggesting that IL-12 and IL-15 may act on different CB apoptotic pathways.
IL-15 greatly enhanced the proliferation of CB lymphocyte assessed by PI to levels comparable to that of APB MNCs, while the lymphocyte proliferation assay failed to detect significant changes by culturing with IL-15 for 3 days. Our finding that IL-12+IL-15 resulted in enhancement of both proliferation and apoptosis in CB and APB MNCs is in agreement with Naora et al 24 who demonstrated that increased apoptosis accompanied IL-15-induced proliferation of CD56 + cells in HIV-infected patients. Our study also demonstrated for the first time that IL-12 and IL-15-induced proliferation of CB NK and T cells is associated with up-regulation of their Fas (CD95) expression, paving the way for subsequent apoptosis. Our previous study has shown that IL-12 alone and IL-12+IL-15 downregulate CB CD3
+ expression in 7 day cultures, while IL-15 alone had no effect. 25 We next determined the effect of IL-12 and IL-15 on the proliferation and apoptosis of particular CB lymphocyte subsets. IL-12 and IL-15, when used alone, increased the proliferation, but not apoptosis of CB CD8 + and CD56 NK cells with IL-12+IL-15 in vitro results in NK cell apoptosis mediated through a tumor necrosis factor-alphadependent mechanism. Thus, simultaneous signaling via components of IL-12R and IL-2R appear to be critical for induction of apoptosis.
Bone Marrow Transplantation
Although incriminated as a contributing factor in GVHD after BM transplantation, 27 IL-12 has been shown to inhibit GVHD via promoting apoptosis of donor CD4 + T cells, while preserving the GVL effect mediated by donor CD8 + T cells. 28 IL-15 is effective in stimulating anti-tumor effects post transplantation 29 and appears to be less toxic than IL-2. 30 According to our results, a regimen combining IL-12+IL-15 may be most effective in augmenting the GVL effect post CB transplant, as it induced the greatest degree of proliferation in CB CD8/CD56 effector cells. Furthermore, our finding may have therapeutic implications in designing combination therapies involving IL-12+IL-15 after CB transplant. Coadministration of IL-12+IL-15 to mice resulted in lethal cytokine-induced shock cascade whereas IL-15 provided alone did not result in mortality. 31 IL-15 may therefore be a key cofactor in IL-12-induced toxicity in vivo by potentiating IL-12-induced cytokine release. 32 Further studies are needed to determine the mechanism underlying our observations and their biological significance in the neonatal immune response and in the setting of CB transplantation.
